Heterogeneity of non-cancerous liver parenchyma on gadoxetic acid-enhanced MRI: an imaging biomarker for hepatocellular carcinoma development in chronic liver disease

2016 ◽  
Vol 71 (5) ◽  
pp. 432-437 ◽  
Author(s):  
Y. Asayama ◽  
A. Nishie ◽  
K. Ishigami ◽  
Y. Ushijima ◽  
Y. Takayama ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Liver Parenchyma ◽  
Chronic Liver ◽  
Gadoxetic Acid ◽  
Imaging Biomarker ◽  
Enhanced Mri

Hepatocellular carcinoma in patients with chronic liver disease: A comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT

2012 ◽  
Vol 67 (2) ◽  
pp. 148-156 ◽  
Author(s):  
C.-K. Baek ◽  
J.-Y. Choi ◽  
K.-A. Kim ◽  
M.-S. Park ◽  
J.S. Lim ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Chronic Liver ◽  
Gadoxetic Acid ◽  
Enhanced Mri

scholarly journals Does the Functional Liver Imaging Score Derived from Gadoxetic Acid–enhanced MRI Predict Outcomes in Chronic Liver Disease?

Radiology ◽  
2020 ◽  
Vol 294 (1) ◽  
pp. 98-107 ◽  
Author(s):  
Nina Bastati ◽  
Lucian Beer ◽  
Mattias Mandorfer ◽  
Sarah Poetter-Lang ◽  
Dietmar Tamandl ◽  
...  
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Chronic Liver ◽  
Gadoxetic Acid ◽  
Liver Imaging ◽  
Enhanced Mri
Sign in / Sign up

Export Citation Format

Share Document